ATE121457T1 - Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck. - Google Patents

Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck.

Info

Publication number
ATE121457T1
ATE121457T1 AT89911558T AT89911558T ATE121457T1 AT E121457 T1 ATE121457 T1 AT E121457T1 AT 89911558 T AT89911558 T AT 89911558T AT 89911558 T AT89911558 T AT 89911558T AT E121457 T1 ATE121457 T1 AT E121457T1
Authority
AT
Austria
Prior art keywords
ace
hypertension
nucleic acid
human
angiotension
Prior art date
Application number
AT89911558T
Other languages
English (en)
Inventor
Florent Soubrier
Francois Alhenc-Gelas
Christine Hubert
Pierre Corvol
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE121457T1 publication Critical patent/ATE121457T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89911558T 1988-09-27 1989-09-27 Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck. ATE121457T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8812620A FR2636968B1 (fr) 1988-09-27 1988-09-27 Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle

Publications (1)

Publication Number Publication Date
ATE121457T1 true ATE121457T1 (de) 1995-05-15

Family

ID=9370447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89911558T ATE121457T1 (de) 1988-09-27 1989-09-27 Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck.

Country Status (7)

Country Link
US (2) US5359045A (de)
EP (1) EP0388466B1 (de)
JP (1) JP2854062B2 (de)
AT (1) ATE121457T1 (de)
DE (1) DE68922297T2 (de)
FR (1) FR2636968B1 (de)
WO (1) WO1990003435A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678285A1 (fr) * 1991-06-27 1992-12-31 Inst Nat Sante Rech Med Moyens et procedes pour l'etude du polymorphisme genetique de l'enzyme de conversion de l'angiotensine 1.
WO1997003196A1 (en) 1995-07-11 1997-01-30 Magainin Pharmaceuticals Inc. CLONING, TISSUE DISTRIBUTION, AND FUNCTIONAL ANALYSIS OF Na+/H+ EXCHANGER ISOFORM, NHE3
US5800990A (en) * 1995-12-06 1998-09-01 Regents Of The University Of Colorado Angiotensin-converting enzyme genetic variant screens
EP0929667A1 (de) * 1996-10-04 1999-07-21 Michael Mulvany Kennzeichen für bluthochdruck
US6376182B1 (en) 1997-05-14 2002-04-23 Medical University Of South Carolina Methods and compositions for correlating tissue kallikrein gene promoter polymorphisms with treatment of essential hypertension
US5948616A (en) * 1997-05-14 1999-09-07 Musc Foundation For Research Development Methods and compositions of correlating tissue kallikrein gene promoter polymorphisms with essential hypertension
US6610497B1 (en) * 1997-12-11 2003-08-26 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6989363B1 (en) 1997-12-11 2006-01-24 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6194556B1 (en) 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6525185B1 (en) * 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension
WO2000020032A1 (en) * 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
AU4691900A (en) * 1999-05-13 2000-12-05 Zymogenetics Inc. Zace2: a human metalloenzyme
AU1410801A (en) * 1999-11-17 2001-05-30 Compugen Ltd. Variants of alternative splicing
AU3499801A (en) * 2000-02-11 2001-08-20 Schepens Eye Res Inst Isolation and transplantation of retinal stem cells
US7514213B2 (en) * 2002-11-15 2009-04-07 Quest Diagnostics Investments Incorporated Compositions and methods for determining genotypes
US20090217402A1 (en) * 2005-05-20 2009-08-27 Emory University Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
WO2008034177A1 (en) * 2006-09-18 2008-03-27 The University Of Sydney Equine performance test
ES2700980T3 (es) 2012-02-17 2019-02-20 Schepens Eye Res Inst Perfil fenotípico de células progenitoras de retina humana

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
JPS61186399A (ja) * 1984-07-30 1986-08-20 Fuji Yakuhin Kogyo Kk 抗ヒトアンジオテンシン変換酵素抗体

Also Published As

Publication number Publication date
EP0388466A1 (de) 1990-09-26
JPH03502643A (ja) 1991-06-20
FR2636968B1 (fr) 1992-01-03
US5480793A (en) 1996-01-02
EP0388466B1 (de) 1995-04-19
JP2854062B2 (ja) 1999-02-03
WO1990003435A2 (fr) 1990-04-05
DE68922297T2 (de) 1995-09-14
FR2636968A1 (fr) 1990-03-30
US5359045A (en) 1994-10-25
WO1990003435A3 (fr) 1990-05-31
DE68922297D1 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
ATE121457T1 (de) Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck.
Ching et al. Some aspects of the venom proteome of the Colubridae snake Philodryas olfersii revealed from a Duvernoy’s (venom) gland transcriptome
Rothnagel et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens
Pangburn et al. Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I
ES2118593T3 (es) Analogos de nucleotidos de pteridina como sondas fluorescentes de adn.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ES2546182T3 (es) Métodos y kits para análisis de metilación en trastornos proliferativos celulares colorrectales
Certa et al. High density oligonucleotide array analysis of interferon-α2a sensitivity and transcriptional response in melanoma cells
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
DE69835509D1 (de) Verfahren zur bestimmung des kardiovasculären status und zusammensetzungen zu deren verwendung
WO1998006841A3 (en) Two human nsp-like proteins
DE69623786D1 (de) Mch2, EINE APOPTOTISCHE CYSTEIN-PROTEASE, ZUSAMMENSETZUNGEN FÜR IHRE PRÄPARATION UND METHODEN FÜR IHRE VERWENDUNG
DE69034060D1 (de) Nukleinsäure, die für das menschliche testikulare angiotensin konvertierende enzym (ace) kodiert, und seine anwendungen, insbesondere für die in vitro-detektion des enzyms im organismus
WO1997044454A3 (en) Human phospholipase inhibitor
Moolman-Smook et al. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy.
DE69632963D1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
MX9709338A (es) Receptor de transmembrana-siete de tipo c5a.
Martinez et al. Threonines at position 174 and 235 of the angiotensinogen polypeptide chain are related to familial history of hypertension in a Spanish-Mediterranean population
DE60025011D1 (de) Dna polymerase lambda und ihre verwendungen
Li et al. Molecular analysis of a novel cathepsin K gene mutation in a Chinese child with pycnodysostosis
DK1287142T3 (da) Nukleinsyremolekyle omfattende en for et SDF-1 gamma chemokin, en neuropeptid-præcursor eller mindst et neuropeptid kodende nukleinsyresekvens
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
WO2007134718A2 (en) Use of adamts4 gene and protein polymorphisms
DE60334408D1 (de) Nsäuren
MX9701596A (es) Un homologo de quinasa de proteina activada por mitogeno humana.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee